DOCSLIB.ORG

Supporting Information

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Supporting Information Supporting Information Wade et al. 10.1073/pnas.1423754112 Materials and Methods alone (soluble) or after a 20-min incubation at 37 °C with 1-pal- Primary Sequence Alignment and Cluster Analysis. Sequence align- mitoyl-2-oleoyl-sn-glycero-3-phosphocholine/cholesterol liposomes ment of the CDC primary structures was performed using ClustalW (20 μL) to allow assembly of the oligomer. For all experiments, (1), and the phylogenetic trees were derived from a maximum emission scans of the unlabeled soluble or liposome-bound toxin parsimony analysis of the ClustalW-derived alignments, using were measured and subtracted from the experimental data to Mega6geneanalysissoftware(2). eliminate any changes in fluorescence not resulting from the NBD probe. An excitation wavelength of 480 nm and 4 nm bandpass Steady-State Fluorometry. Steady-state experiments were performed were used. Resolution was set to 1 nm with 0.1 s integration. on a Fluorolog-3 Spectrofluorometer with the FluorEssence soft- β4β5 disengagement was measured as previously described (3) ware. The polarity of the environment surrounding Cys-substituted for PFOV322C or PFOV322C:Y181A, where a 1:1 molar ratio of PFOE183C or PFOK336C (176 pmol total: 25% NBD labeled, 75% NBD-labeled to unlabeled protein was used to minimize NBD unlabeled) was determined by performing an NBD emission scan self-quenching in the oligomeric complex. Settings for measuring (500–600 nm) of proteins either in buffer (2.5 mL final volume) NBD emission were set as described above. 1. Larkin MA, et al. (2007) Clustal W and Clustal X version 2.0. Bioinformatics 23(21): 3. Ramachandran R, Tweten RK, Johnson AE (2004) Membrane-dependent conforma- 2947–2948. tional changes initiate cholesterol-dependent cytolysin oligomerization and inter- 2. Tamura K, et al. (2011) MEGA5: Molecular evolutionary genetics analysis using maxi- subunit beta-strand alignment. Nat Struct Mol Biol 11(8):697–705. mum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol 28(10):2731–2739. Wade et al. www.pnas.org/cgi/content/short/1423754112 1of5 93 Bacillus anthracis (Anthrolysin) E K N Bacillus thuringensis (Thuringiolysin) E K N 100 Clostridium drakei E K N 90 Bacillus weihenstephanensis E K N Bacillus cereus (Cereolysin) E K N Brevibacillus brevis E K N Lysinibacillus sphaericus (Sphaericolysin) E K N 95 Paenibacillus alvei (Alveolysin) E K N Clostridium hydrogeniformans E K N Clostridium lundense E K N Clostridium perfringens (Perfringolysin O) E K N Peptostreptococcaceae bacterium VA2 E K N Clostridium bifermentans E K N 99 Streptococcus urinalis E K N 90 Streptococcus ictaluri E K N 100 Streptococcus didelphis E K N Streptococcus canis E K N 98 Streptococcus pyogenes (Streptolysin O) E K N 100 Streptococcus dysgalactiae subsp. equisimilis (Equisimilysin) E K N 92 Clostridium butyricum E K N Clostridium novyi NT (Novyiolysin I) D K G Clostridium tetani (Tetanolysin) D K G 99 Clostridium botulinum (Botulinolysin) D K G Clostridium novyi NT (Novyiolysin II) D K G Enterobacter lignolyticus* (Enterolysin) E K G Butyrivibrio sp. LB2008 S E D 98 92 99 Desulfobulbus propionicus* (Desulfolysin) S D G Austwickia chelonae E G G Listeria ivanovii (Ivanolysin) Q G G Listeria seeligeria (Seeligeriolysin) D G G 87 100 Listeria monocytogenes (Listeriolysin) D G G 91 100 Listeria innocua D G G Trueperella pyogenes (Pyolysin) E G G 100 Arcanobacterium haemolyticum (Arcanolysin) E G G Streptococcus suis (Suilysin) E G G 100 Streptococcus pneumoniae (Pneumolysin) K G G 100 Streptococcus mitis (Mitilysin) K G G Lactobacillus iners (Inerolysin) T G G Gemella bergeri E G G 100 Gemella cuniculi E G G Streptococcus intermedius (Intermedilysin)** S G G Gardnerella vaginosis (Vaginolysin)** S G G Streptococcus pseudopneumoniae** S G G 100 Streptococcus mitis (Lectinolysin)** S N G Streptococcus tigurinus** S E G Fig. S1. CDC phylogenetic tree. The evolutionary history of the CDCs was inferred using the maximum parsimony method. Tree 1 of the five most parsi- monious trees is shown (length = 3,065). The consistency index is 0.495063, the retention index is 0.673756, and the composite index is 0.336548 for all sites. The percentage of replicate trees in which the associated taxa clustered together in the bootstrap test (200 replicates) is shown next to the branches (1). The maximum parsimony tree was obtained using the Subtree-Pruning-Regrafting algorithm (2), with search level 1, in which the initial trees were obtained by the random addition of sequences (10 replicates). The analysis involved 45 CDC primary structures. Positions containing gaps and missing data were eliminated. A total of 387 positions were in the final dataset. The alignment of their primary structures was carried out using ClustalW (3), and the evolutionary analyses were conducted in MEGA5 (4). The analogous residues for PFO residues E183, K336, and N197 are shown to the right of the phylogenetic tree. Note that Legend continued on following page Wade et al. www.pnas.org/cgi/content/short/1423754112 2of5 different strains of Streptococcus mitis have been shown to express a pneumolysin-like CDC (5) or a lectinolysin-like (6) CDC. *Gram-negative species. **Proven or predicted to use CD59 instead of cholesterol as their primary receptor based on the conserved YXYX14RS motif in domain 4 (6–8). 1. Felsenstein J (1985) Confidence limits on phylogenies: An approach using the bootstrap. Evolution 39:783–791. 2. Nei M, Kumar S (2000) Molecular Evolution and Phylogenetics (Oxford Univ. Press, New York). 3. Larkin MA, et al. (2007) Clustal W and Clustal X version 2.0. Bioinformatics 23(21):2947–2948. 4. Tamura K, et al. (2011) MEGA5: Molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol 28(10): 2731–2739. 5. Jefferies J, et al. (2007) Identification of a secreted cholesterol-dependent cytolysin (mitilysin) from Streptococcus mitis. J Bacteriol 189(2):627–632. 6. Farrand S, et al. (2008) Characterization of a streptococcal cholesterol-dependent cytolysin with a lewis y and b specific lectin domain. Biochemistry 47(27):7097–7107. 7. Giddings KS, Zhao J, Sims PJ, Tweten RK (2004) Human CD59 is a receptor for the cholesterol-dependent cytolysin intermedilysin. Nat Struct Mol Biol 11(12):1173–1178. 8. Wickham SE, et al. (2011) Mapping the intermedilysin-human CD59 receptor interface reveals a deep correspondence with the binding site on CD59 for complement binding proteins C8alpha and C9. J Biol Chem 286(23):20952–20962. E183C 8×105 Soluble Prepore 6×105 4×105 FI (au) FI 2×105 0 500 520 540 560 580 600 Wavelength (nm) K336C 8×105 Soluble Prepore 6×105 4×105 FI (au) FI 2×105 0 500 520 540 560 580 600 Wavelength (nm) Fig. S2. E183 and K336 make a polar-to-nonpolar transition on prepore formation. PFOE183C and PFOK336C were modified via their Cys sulfhydryls with the environmentally sensitive fluorescent probe NBD (1), and the fluorescence emission was measured for the soluble monomer and the membrane-bound prepore. Each mutant was examined individually with a 10-fold molar excess of the cognate unlabeled mutant to separate the probes in the oligomer (on average, by about 20 nm), thereby minimizing any contribution to the fluorescence change resulting from self-quenching of the NBD probe. 1. Shepard LA, et al. (1998) Identification of a membrane-spanning domain of the thiol-activated pore-forming toxin Clostridium perfringens perfringolysin O: An alpha-helical to beta- sheet transition identified by fluorescence spectroscopy. Biochemistry 37(41):14563–14574. Wade et al. www.pnas.org/cgi/content/short/1423754112 3of5 6 1×10 Soluble 8×105 Liposomes 6×105 5 FI (au) 4×10 2×105 0 500 520 540 560 580 600 Wavelength (nm) Soluble 6 1.2×10 Liposomes 8.0×105 FI (au) 4.0×105 0.0 500 520 540 560 580 600 Wavelength (nm) Fig. S3. Mutation of Y181 in PFO prevents the disengagement of β5 from β4. The disengagement of β5 from β4 can be monitored by the nonpolar-to-polar transition of an NBD probe coupled to the sulfhydryl of Cys-substituted Val-322, which is buried under the β5α1 loop in the PFO monomer (1) (Fig. 1A). As shown, an NBD probe on the Cys sulfhydryl of PFOV322C:Y181A does not undergo the nonpolar-to-polar transition (Bottom) that is observed with PFOV322C (Upper). 1. Ramachandran R, Tweten RK, Johnson AE (2004) Membrane-dependent conformational changes initiate cholesterol-dependent cytolysin oligomerization and intersubunit beta-strand alignment. Nat Struct Mol Biol 11(8):697–705. Wade et al. www.pnas.org/cgi/content/short/1423754112 4of5 D152 (monomer) D152 (oligomer) 2.2 Å 16.1 Å K110 (monomer) K110 (oligomer) Fig. S4. Staphylococcus aureus α-hemolysin exhibits a putative electrostatic trigger. (Left) Dimer from the α-hemolysin oligomeric structure (1) overlaid with the α-hemolysin monomer structure (2). The TMHs (cyan and coral) are shown as folded structures in the monomer and as extended structures in the oligomer. (Right) Close-up of the relative position of K110 in the overlay of soluble monomer with the oligomer pore. The relative position of D152 is also shown in the soluble monomer (green) and the pore complex (yellow). The distance separating K110 and D152 charged centroids (dashed lines) before pore formation is ∼16 Å and is only 2 Å in the oligomeric pore. Mutation of either residue traps α-hemolysin in a stable prepore structure (3, 4). The arrow shows the relative change in position (∼16 Å) of K110 in the overlaid monomer and pore complex. Ribbon structures were created and rendered with UCSF Chimera. 1. Song L, et al. (1996) Structure of staphylococcal alpha-hemolysin, a heptameric transmembrane pore. Science 274(5294):1859–1866. 2. Foletti D, et al.
Load more

Recommended publications
  • Fecal Bacteriology of Colonic Polyp Patients and Control Patients'
    [CANCER RESEARCH35,3407-3417,November1975] Fecal Bacteriology of Colonic Polyp Patients and Control Patients' Sydney M . Finegold,2 Dennis J . Flora, Howard R . Attebery, and Vera L. Sutter Medical Service, Wadsworth Hospital Center, Veterans Administration and Department ofMedicine, University ofCalifornia at Los Angeles School of Medicine, Los Angeles, California 9tXl24 Summary and villous adenomata are rare in populations with a low incidence of colon cancer and that they are found with the Feces from 25 subjects with colonic polyps (multiple highest incidence in areas where colon cancer has the adenomatous, large single, or single with atypia) and from highest prevalence. Berge et a!. (3) note a close association 25 matched control subjects were studied by detailed between polyps and carcinoma, both tending to occur in the quantitative aerobic and anaerobic techniques, using a large same distribution. Fifty-nine % of polypoid tumors more battery of culture media and several atmospheric condi than 10 mm in diameter were carcinomas, as were 16.9% of tions. Over 55% of organisms detected on microscopic count those 5 to 10 mm in size. were recovered anaerobically. In several cases, there were There has been much speculation on interrelationships significantly different numbers of organisms of specific between diet, intestinal bacteria, intestinal polyps, and types recovered from the two different populations studied. carcinoma (I, 2, 6—8). However, these differed from organisms with “statistical The present study was designed to compare the fecal significance― noted in a previous study from this laboratory bacterial flora of 25 patients with colonic polyps (chiefly involving two different diet groups (Japanese Americans on multiple adenomatous polyps) with that of 25 subjects either a Japanese or a Western diet).
    [Show full text]
  • Common Commensals
    Common Commensals Actinobacterium meyeri Aerococcus urinaeequi Arthrobacter nicotinovorans Actinomyces Aerococcus urinaehominis Arthrobacter nitroguajacolicus Actinomyces bernardiae Aerococcus viridans Arthrobacter oryzae Actinomyces bovis Alpha‐hemolytic Streptococcus, not S pneumoniae Arthrobacter oxydans Actinomyces cardiffensis Arachnia propionica Arthrobacter pascens Actinomyces dentalis Arcanobacterium Arthrobacter polychromogenes Actinomyces dentocariosus Arcanobacterium bernardiae Arthrobacter protophormiae Actinomyces DO8 Arcanobacterium haemolyticum Arthrobacter psychrolactophilus Actinomyces europaeus Arcanobacterium pluranimalium Arthrobacter psychrophenolicus Actinomyces funkei Arcanobacterium pyogenes Arthrobacter ramosus Actinomyces georgiae Arthrobacter Arthrobacter rhombi Actinomyces gerencseriae Arthrobacter agilis Arthrobacter roseus Actinomyces gerenseriae Arthrobacter albus Arthrobacter russicus Actinomyces graevenitzii Arthrobacter arilaitensis Arthrobacter scleromae Actinomyces hongkongensis Arthrobacter astrocyaneus Arthrobacter sulfonivorans Actinomyces israelii Arthrobacter atrocyaneus Arthrobacter sulfureus Actinomyces israelii serotype II Arthrobacter aurescens Arthrobacter uratoxydans Actinomyces meyeri Arthrobacter bergerei Arthrobacter ureafaciens Actinomyces naeslundii Arthrobacter chlorophenolicus Arthrobacter variabilis Actinomyces nasicola Arthrobacter citreus Arthrobacter viscosus Actinomyces neuii Arthrobacter creatinolyticus Arthrobacter woluwensis Actinomyces odontolyticus Arthrobacter crystallopoietes
    [Show full text]
  • Bacterial Diversity and Functional Analysis of Severe Early Childhood
    www.nature.com/scientificreports OPEN Bacterial diversity and functional analysis of severe early childhood caries and recurrence in India Balakrishnan Kalpana1,3, Puniethaa Prabhu3, Ashaq Hussain Bhat3, Arunsaikiran Senthilkumar3, Raj Pranap Arun1, Sharath Asokan4, Sachin S. Gunthe2 & Rama S. Verma1,5* Dental caries is the most prevalent oral disease afecting nearly 70% of children in India and elsewhere. Micro-ecological niche based acidifcation due to dysbiosis in oral microbiome are crucial for caries onset and progression. Here we report the tooth bacteriome diversity compared in Indian children with caries free (CF), severe early childhood caries (SC) and recurrent caries (RC). High quality V3–V4 amplicon sequencing revealed that SC exhibited high bacterial diversity with unique combination and interrelationship. Gracillibacteria_GN02 and TM7 were unique in CF and SC respectively, while Bacteroidetes, Fusobacteria were signifcantly high in RC. Interestingly, we found Streptococcus oralis subsp. tigurinus clade 071 in all groups with signifcant abundance in SC and RC. Positive correlation between low and high abundant bacteria as well as with TCS, PTS and ABC transporters were seen from co-occurrence network analysis. This could lead to persistence of SC niche resulting in RC. Comparative in vitro assessment of bioflm formation showed that the standard culture of S. oralis and its phylogenetically similar clinical isolates showed profound bioflm formation and augmented the growth and enhanced bioflm formation in S. mutans in both dual and multispecies cultures. Interaction among more than 700 species of microbiota under diferent micro-ecological niches of the human oral cavity1,2 acts as a primary defense against various pathogens. Tis has been observed to play a signifcant role in child’s oral and general health.
    [Show full text]
  • Frequent Detection of Streptococcus Tigurinus in the Human Oral
    Zbinden et al. BMC Microbiology 2014, 14:231 http://www.biomedcentral.com/1471-2180/14/231 RESEARCH ARTICLE Open Access Frequent detection of Streptococcus tigurinus in the human oral microbial flora by a specific 16S rRNA gene real-time TaqMan PCR Andrea Zbinden1,4*,FatmaAras2, Reinhard Zbinden1, Forouhar Mouttet1, Patrick R Schmidlin2, Guido V Bloemberg1† and Nagihan Bostanci3† Abstract Background: Many bacteria causing systemic invasive infections originate from the oral cavity by entering the bloodstream. Recently, a novel pathogenic bacterium, Streptococcus tigurinus, was identified as causative agent of infective endocarditis, spondylodiscitis and meningitis. In this study, we sought to determine the prevalence of S. tigurinus in the human oral microbial flora and analyzed its association with periodontal disease or health. Results: We developed a diagnostic highly sensitive and specific real-time TaqMan PCR assay for detection of S. tigurinus in clinical samples, based on the 16S rRNA gene. We analyzed saliva samples and subgingival plaque samples of a periodontally healthy control group (n = 26) and a periodontitis group (n = 25). Overall, S. tigurinus was detected in 27 (53%) out of 51 patients. There is no significant difference of the frequency of S. tigurinus detection by RT-PCR in the saliva and dental plaque samples in the two groups: in the control group, 14 (54%) out of 26 individuals had S. tigurinus either in the saliva samples and/or in the plaque samples; and in the periodontitis group, 13 (52%) out of 25 patients had S. tigurinus in the mouth samples, respectively (P = 0.895). The consumption of nicotine was no determining factor.
    [Show full text]
  • C-Di-AMP Signaling Is Required for Bile Salts Resistance and Long-Term
    bioRxiv preprint doi: https://doi.org/10.1101/2021.08.23.457418; this version posted August 23, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. 1 Title: c-di-AMP signaling is required for bile salts resistance and long-term 2 colonization by Clostridioides difficile 3 Authors: Marine Oberkampf1†, Audrey Hamiot1‡†, Pamela Altamirano-Silva2, Paula Bellés- 4 Sancho1§, Yannick D. N. Tremblay1¶, Nicholas DiBenedetto3, Roland Seifert4, Olga 5 Soutourina5, Lynn Bry3,6, Bruno Dupuy1* and Johann Peltier1,5* 6 7 Affiliations: 8 1. Laboratoire Pathogenèse des Bactéries Anaérobies, CNRS-2001, Institut Pasteur, 9 Université de Paris, F-75015 Paris, France. 10 2. Centro de Investigación en Enfermedades Tropicales, Facultad de Microbiología, 11 Universidad de Costa Rica, San José, Costa Rica 12 3. Massachusetts Host-Microbiome Center, Dept. Pathology, Brigham & Women’s Hospital, 13 Harvard Medical School, Boston, MA. 14 4. Institute of Pharmacology & Research Core Unit Metabolomics, Hannover Medical 15 School, Hannover, Germany. 16 5. Université Paris-Saclay, CEA, CNRS, Institute for Integrative Biology of the Cell (I2BC), 17 91198, Gif-sur-Yvette, France 18 6. Clinical Microbiology Laboratory, Department of Pathology, Brigham & Women’s 19 Hospital, Boston, MA. 20 21 * Co-corresponding authors. Emails: [email protected]; [email protected] 22 saclay.fr 23 24 † These authors contributed equally to the studies undertaken. 25 ‡ Present address: UMR UMET, INRA, CNRS, Univ. Lille 1, 59650 Villeneuve d'Ascq, 26 France.
    [Show full text]
  • Comparative Genomic Analysis of the Emerging Pathogen
    bioRxiv preprint doi: https://doi.org/10.1101/468462; this version posted November 12, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. 1 Comparative genomic analysis of the emerging pathogen Streptococcus 2 pseudopneumoniae: novel insights into virulence determinants and 3 identification of a novel species-specific molecular marker 4 5 Geneviève Garriss1†, Priyanka Nannapaneni1†, Alexandra S. Simões2, Sarah Browall1, Raquel Sá- 6 Leão2, 3, Herman Goossens4, Herminia de Lencastre2, 5, Birgitta Henriques-Normark 1, 6, 7 7 8 9 10 1Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, SE-171 77 11 Stockholm, Sweden 12 2Laboratory of Molecular Genetics, Instituto de Tecnologia Química e Biológica Antonio Xavier, 13 Universidade Nova de Lisboa, Oeiras, Portugal 14 3Department of Plant Biology, Faculdade de Ciências, Universidade de Lisboa, Lisboa, Portugal. 15 4Laboratory of Medical Microbiology, Vaccine & Infectious Disease Institute (VAXINFECTIO), 16 University of Antwerp, Antwerp Belgium 17 5Laboratory of Microbiology and Infectious Diseases, The Rockefeller University, New York, NY, 18 USA 19 6Public Health Agency Sweden, SE-171 82 Solna, Sweden 20 7Department of Laboratory Medicine, Division of Clinical Microbiology, Karolinska University 21 Hospital, Solna, Sweden. 22 23 †These authors contributed equally. 24 25 Corresponding author: Birgitta Henriques-Normark, Professor, MD, Karolinska University hospital 26 and Karolinska Institutet, MTC, Nobels väg 16, SE-171 77 Stockholm, Sweden, 27 Email: [email protected] 28 29 30 bioRxiv preprint doi: https://doi.org/10.1101/468462; this version posted November 12, 2018.
    [Show full text]
  • Mechanisms of Interaction Between Haemophilus Parainfluenzae and Streptococcus Mitis
    University of Rhode Island DigitalCommons@URI Open Access Dissertations 2021 MECHANISMS OF INTERACTION BETWEEN HAEMOPHILUS PARAINFLUENZAE AND STREPTOCOCCUS MITIS Dasith Perera Follow this and additional works at: https://digitalcommons.uri.edu/oa_diss MECHANISMS OF INTERACTION BETWEEN HAEMOPHILUS PARAINFLUENZAE AND STREPTOCOCCUS MITIS BY DASITH PERERA A DISSERTATION SUBMITTED IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE DEGREE OF DOCTOR OF PHILOSOPHY IN CELL & MOLECULAR BIOLOGY UNIVERSITY OF RHODE ISLAND 2021 DOCTOR OF PHILOSOPHY DISSERTATION OF DASITH PERERA APPROVED: Thesis Committee: Matthew Ramsey, Major professor David Nelson David Rowley Brenton DeBoef DEAN OF THE GRADUATE SCHOOL UNIVERSITY OF RHODE ISLAND 2021 ABSTRACT The human oral cavity is a complex polymicrobial environment, home to an array of microbes that play roles in health and disease. Oral bacteria have been shown to cause an array of systemic diseases and are particularly concerning to type II diabetics (T2D) with numerous predispositions that exacerbate bacterial infection. In this dissertation, we investigated the serum of healthy subjects and T2D subjects to determine whether we see greater translocation of oral bacteria into the bloodstream of T2D indiviDuals. We didn’t observe any significant enrichment of oral taxa, however we detected the presence of an emerging pathogen, Acinetobacter baumannii that is also associated with impaired inflammation in T2D. While some are associated with disease, many oral taxa are important in the pre- vention of disease. In this dissertation we investigated the interactions between two abundant health-associated commensal microbes, Haemophilus parainfluenzae and Streptococcus mitis. We demonstrated that H. parainfluenzae typically exists adjacent to Mitis group streptococci in vivo in healthy subjects.
    [Show full text]
  • Optimization and Production of Hyaluronidase by Streptococcus
    lar Rese cu ar le ch o & m o T i h B e f r Journal of a Mahesh et al., J Biomol Res Ther 2012, 1:1 o p l e a u n t r i DOI: 10.4172/2167-7956.1000101 c u s o J ISSN: 2167-7956 Bioresearch Communications Research Article Open Access Optimization and Production of Hyaluronidase by Streptococcus mitis MTCC 2695 Narayanan Mahesh1*, Srinivasan Balakumar1, R Parkavi1, Arunadevi Ayyadurai1 and Rangarajan Vivek2 1Department of Chemistry and Biosciences, Srinivasa Ramanujan Centre, SASTRA University, Kumbakonam – 612001, India 2Department of Biotechnology, Indian Institute of Technology, Kharagpur-721 302, India Abstract Hyaluronidase was produced by submerged fermentation from Streptococcus mitis. The possibility of using Streptococcus mitis for enzyme production has been recently investigated. In this study, the physical and nutritional parameters were optimized to improve the production of hyaluronidase by Streptococcus mitis and it was accessed. Maximum production of hyaluronidase was obtained when 5% starch supplemented as carbon source achieved by employing (98.7U/ml) and followed by ammonium chloride (140.4U/ml) incubation period about 48 hours showed (108.9U/ml) and temperature at 37°C showed (179.9U/ml). The maximum enzyme yield on pH 4 is (110.7U/ml). The production of hyaluronidase by means of immobilized Streptococcus mitis was evaluated and a maximum production was obtained with the medium was inoculated with 100 beads (591U/ml) which was more than that of mobilized cells. Keywords: Hyaluronidase; Streptococcus mitis; Submerged fermen- prevents their being recognized by phagocytes of the immune system tation; Hyaluronan; Immobilization [11,28].
    [Show full text]
  • Identification of Clinically Relevant Streptococcus and Enterococcus
    pathogens Article Identification of Clinically Relevant Streptococcus and Enterococcus Species Based on Biochemical Methods and 16S rRNA, sodA, tuf, rpoB, and recA Gene Sequencing Maja Kosecka-Strojek 1,* , Mariola Wolska 1, Dorota Zabicka˙ 2 , Ewa Sadowy 3 and Jacek Mi˛edzobrodzki 1 1 Department of Microbiology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, 30-387 Krakow, Poland; [email protected] (M.W.); [email protected] (J.M.) 2 Department of Molecular Microbiology, National Medicines Institute, 00-725 Warsaw, Poland; [email protected] 3 Department of Epidemiology and Clinical Microbiology, National Medicines Institute, 00-725 Warsaw, Poland; [email protected] * Correspondence: [email protected]; Tel.: +48-12-664-6365 Received: 13 October 2020; Accepted: 9 November 2020; Published: 11 November 2020 Abstract: Streptococci and enterococci are significant opportunistic pathogens in epidemiology and infectious medicine. High genetic and taxonomic similarities and several reclassifications within genera are the most challenging in species identification. The aim of this study was to identify Streptococcus and Enterococcus species using genetic and phenotypic methods and to determine the most discriminatory identification method. Thirty strains recovered from clinical samples representing 15 streptococcal species, five enterococcal species, and four nonstreptococcal species were subjected to bacterial identification by the Vitek® 2 system and Sanger-based sequencing methods targeting the 16S rRNA, sodA, tuf, rpoB, and recA genes. Phenotypic methods allowed the identification of 10 streptococcal strains, five enterococcal strains, and four nonstreptococcal strains (Leuconostoc, Granulicatella, and Globicatella genera). The combination of sequencing methods allowed the identification of 21 streptococcal strains, five enterococcal strains, and four nonstreptococcal strains.
    [Show full text]
  • Title Layout
    Antibiotics – an update on recently approved and investigational drugs Jenner Minto, Pharm.D. Disclosures • Nothing to disclose Learning Objectives • Describe the use of new antibacterial agents in clinical practice • Describe the therapeutic potential of antibiotics currently in development Assessment Questions 1. Which of the following statements regarding new antibacterial agents is true? A. Most are FDA approved to treat a broad range of infections B. Recently approved antibiotics are likely to become first-line agents C. Many have a novel mechanism of action D. Most are reserved for infections caused by organisms that are resistant to existing antibiotics 2. The majority of antibiotics currently in development target which pathogen(s)? A. Gram-positive organisms B. Gram-negative ESKAPE pathogens C. Drug-resistant Neisseria gonorrheae D. Drug-resistant Clostridioides difficile Recently Approved Antibiotics 2018 Approvals Plazomicin (Zemdri®) Evracycline (Xerava®) Sarecycline (Seysara®) Omadacycline (Nuzyra®) Rifamycin (Aemcolo®) 2019 Approvals Imipenem, cliastatin, relebactam (Recabrio®) Pretomanid Lefamulin (Xenleta®) Cefiderocol (Fetroja®) Plazomicin (Zemdri®) Approved • June, 2019 Indications • Complicated urinary tract infections (cUTIs), including pyelonephritis, caused by: E. coli, K. pneumoniae, P. mirabilis, Enterobacter cloacae *Reserved for patients ≥ 18 years of age with limited or no alternative treatment options https://zemdri.com/ https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/210303orig1s000lbl.pdf
    [Show full text]
  • Streptococcus Mitis Strains Causing Severe Clinical Disease in Cancer Patients Samuel A
    RESEARCH Streptococcus mitis Strains Causing Severe Clinical Disease in Cancer Patients Samuel A. Shelburne, Pranoti Sahasrabhojane, Miguel Saldana, Hui Yao, Xiaoping Su, Nicola Horstmann, Erika Thompson, and Anthony R. Flores The genetically diverse viridans group streptococci in species designation and classification schemes over time (VGS) are increasingly recognized as the cause of a va- (7). From a clinical microbiology laboratory standpoint, riety of human diseases. We used a recently developed automated systems have considerable limitations in VGS multilocus sequence analysis scheme to define the species species identification (8,9). The problematic nature of VGS of 118 unique VGS strains causing bacteremia in patients species assignment also extends to16S rRNA sequencing, with cancer; Streptococcus mitis (68 patients) and S. ora- the most widely used genetic tool for species identification lis (22 patients) were the most frequently identified strains. Compared with patients infected with non–S. mitis strains, in clinical and research settings (9,10). patients infected with S. mitis strains were more likely to Outcomes for patients with VGS bacteremia are highly have moderate or severe clinical disease (e.g., VGS shock variable: some patients have minimal symptoms, and oth- syndrome). Combined with the sequence data, whole-ge- ers have a severe infection characterized by hypotension nome analyses showed that S. mitis strains may more pre- and acute respiratory distress syndrome (11). The severe cisely be considered as >2 species. Furthermore, we found infections have been termed VGS shock syndrome (12). that multiple S. mitis strains induced disease in neutrope- Numerous studies have examined the species distribution nic mice in a dose-dependent fashion.
    [Show full text]
  • HIGHLIGHTS of PRESCRIBING INFORMATION These Highlights Do
    HIGHLIGHTS OF PRESCRIBING INFORMATION • Dosage in Pediatric Patients (1 Month of Age to 16 Years): 20 to 40 These highlights do not include all the information needed to use mg/kg/day in 3 or 4 equal doses by intravenous infusion. (2.3) • Alternative Pediatric Patients Dosing: 350 mg/m2/day for serious CLINDAMYCIN IN 0.9% SODIUM CHLORIDE injection safely and 2 effectively. See full prescribing information for CLINDAMYCIN IN infections and 450 mg/m /day for more severe infections. (2.3) 0.9% SODIUM CHLORIDE injection. • Dosage in Neonates (Less than 1 Month of Age): 15 to 20 mg/kg/day in 3 to 4 equal doses by intravenous infusion. (2.3) CLINDAMYCIN IN 0.9% SODIUM CHLORIDE injection, for --------------------- DOSAGE FORMS AND STRENGTHS --------------------- intravenous use Each 50 mL of Clindamycin in 0.9% Sodium Chloride Injection, Initial U.S. Approval: 1989 300 mg/50 mL (6 mg/mL), 600 mg/50 mL (12 mg/mL), and 900 mg/50 mL (18 mg/mL) contains 300 mg, 600 mg, or 900 mg clindamycin, respectively WARNING: CLOSTRIDIOIDES DIFFICILE-ASSOCIATED (as clindamycin phosphate, USP), in a single-dose GALAXY container. (3) DIARRHEA (CDAD) and COLITIS ------------------------------ CONTRAINDICATIONS ----------------------------- See full prescribing information for complete boxed warning. Individuals with a history of hypersensitivity to preparations containing clindamycin or lincomycin. (4) Clostridioides difficile-associated diarrhea (CDAD) has been reported with use of nearly all antibacterial agents, including Clindamycin in ----------------------- WARNINGS AND PRECAUTIONS ----------------------- 0.9% Sodium Chloride Injection and may range in severity from mild • Anaphylactic shock and anaphylactic reactions have been reported. (5.2) diarrhea to fatal colitis.
    [Show full text]